Leotor 40 Tablet contains Torasemide 40 mg, a potent loop diuretic indicated for the management of edema associated with congestive heart failure, renal impairment, and hepatic cirrhosis. Torasemide acts by inhibiting the sodium-potassium-chloride co-transporter in the thick ascending limb of the loop of Henle, promoting increased excretion of sodium, chloride, and water, thereby reducing fluid overload and edema. This medication is also utilized in the treatment of hypertension, either as monotherapy or in combination with other antihypertensive agents, due to its ability to decrease plasma volume and peripheral vascular resistance. Leotor 40 Tablet offers a longer duration of action and improved bioavailability compared to other loop diuretics, allowing for once-daily dosing and enhanced patient compliance. It is essential to monitor electrolyte levels, renal function, and blood pressure regularly during therapy to prevent potential adverse effects such as hypokalemia, dehydration, hypotension, and renal impairment. Patients should be advised to maintain adequate hydration and report symptoms such as dizziness, muscle cramps, or weakness promptly. Leotor 40 Tablet should be used under medical supervision, with dosage adjustments tailored to individual patient response and clinical condition.